Need professional-grade analysis? Visit stockanalysis.com
$18.05B
983.67
1,499
N/A
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY29.28, up 0.93% from the previous close.
Over the past year, 002082 has traded between a low of CNY5.57 and a high of CNY36.24. The stock has gained 403.1% over this period. It is currently 19.2% below its 52-week high.
Wanbangde Pharmaceutical Holding Group Co Ltd has a market capitalization of $18.05B, with a price-to-earnings ratio of 983.67.
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells orthopedic implant devices, including orthopedic implant devices comprised of thoracolumbar fusion, cervical fusion, spinal internal fixation systems, independent fusion devices, unicompartmental knee joints, etc.; medical equipment; disposable sterile medical polymer consumables; and hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020. Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is headquartered in Taizhou, China.
Side-by-side comparison against top Healthcare peers.